Umbreen Arshad Rozell, MD

Description

I'm committed to providing accessible, compassionate and comprehensive care to each of my patients.

Keywords breast diseases, tamoxifen, treatment refractory breast cancer, recurrent breast cancer, invasive breast cancer, metastatic breast cancer, triple negative breast cancer, breast cancer during pregnancy, breast cancer, brca, her2neu receptor, hereditary breast and ovarian cancer, atypical ductal hyperplasia, paget's disease of the breast, microcalcifications, male breast cancer, herceptin, family history of breast cancer, er positive breast cancer, dysplasia of breast, carcinoma in situ of breast, breast lump, breast fine needle aspiration, breast cancer follow up, aromatase inhibitor, atypical lobular hyperplasia, abnormal mammogram, history of breast cancer, ductal carcinoma in situ (dcis), lobular carcinoma in situ (lcis), non steroidal aromatase inhibitors, hormone based chemotherapy, breast cancer biological targeted therapy, targeted molecular therapy, cancer related fatigue, side effects of cancer treatment, breast cancer chemotherapy, breast cancer symptoms, breast cancer risk factors, node positive breast cancer, hormone receptor negative breast cancer, breast cancer immunotherapy, hormone receptor positive breast cancer, her2 positive breast cancer, adjuvant radiation therapy, palb2, p53, lobular neoplasia, er negative breast cancer, myofibroblastoma, breast hyperplasia, breast cancer in young women, inflammatory breast cancer, high risk breast cancer counseling, chemoradiation, cancer immunotherapy, breast cancer genetics.